Ambelvist
Active substance: gadoquatrane
INJECTION · GADOQUATRANE 257.9 mg/mL
United StatesActive
Marketing holder: Bayer HealthCare Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- GADOQUATRANE · 257.9 mg/mL
Registration
- Registration number
- 50419-331
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 50419-331 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 50419-331 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 50419-331 · Verified 2026-10-09 · open in source